Search

Search Results
Results 1581 - 1590 of 6671 for Cancer pain
  • Kliovance
    Drug - 18 Dec 2025
    Consumer Medicine Information (CMI) about Kliovance intended for persons living in Australia.
  • Kliogest
    Drug - 18 Dec 2025
    Consumer Medicine Information (CMI) about Kliogest intended for persons living in Australia.
  • Velcade
    Drug - 16 Dec 2025
    Consumer Medicine Information (CMI) about Velcade intended for persons living in Australia.
  • Piqray
    Drug - 10 Dec 2025
    Consumer Medicine Information (CMI) about Piqray intended for persons living in Australia.
  • Tukysa
    Drug - 27 Nov 2025
    Consumer Medicine Information (CMI) about Tukysa intended for persons living in Australia.
  • Giotrif
    Drug - 31 Oct 2025
    Consumer Medicine Information (CMI) about Giotrif intended for persons living in Australia.
  • Vfend
    Drug - 15 Oct 2025
    Consumer Medicine Information (CMI) about Vfend intended for persons living in Australia.
  • Alimta
    Drug - 21 Aug 2025
    Consumer Medicine Information (CMI) about Alimta intended for persons living in Australia.
  • Zelboraf
    Drug - 2 Jul 2025
    Consumer Medicine Information (CMI) about Zelboraf intended for persons living in Australia.
  • Symptoms and Causes of Pseudomyxoma Peritonei (PMP)
    Health - 29 Jun 2025
    Pseudomyxoma peritonei (PMP) normally starts as a slow-growing tumor in the appendix and it is hence classified as a low-grade mucinous appendiceal neoplasm (LAMN). In rare incidences, it may develop...

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback